Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Sort by:
Need a comprehensive medical report on "Pelage Pharmaceuticals, Inc."?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Phase 2
Active, not recruiting
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: PP405 Topical Vehicle Gel
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Pelage Pharmaceuticals, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT06393452
- Locations
- 🇺🇸
Minnesota Clinical Study Center, New Brighton, Minnesota, United States
🇺🇸DermResearch, Austin, Texas, United States
🇺🇸Stride Clinical Research LLC, Sugar Land, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath